Skip to main content

Fundamental Studies on Bestatin: A Small Molecular Microbial Product Enhancing Immune Responses

  • Conference paper
New Drugs in Cancer Chemotherapy

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 76))

Abstract

The author initiated the screening study of enzyme inhibitors produced by microorganisms in 1965, and found about 50 new microbial products. These small molecular enzyme inhibitors have various bioactivities, but no significant antimicrobial activity. The finding of these inhibitors indicates that microorganisms in nature have acquired the ability to produce various compounds that have no obvious function in the growth of microbial cells and that have widely varied chemical structures [12, 14]. Therefore, if an exact screening method can be established, it is reasonable to search for small molecular microbial products which can modulate immune responses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aoike A (1980) Effect of bestatin on natural killer activity. Small molecular immunomodulators of microbial origin -fundamental and clinical studies of bestatin. Japan Scientific Societies Press, Tokyo

    Google Scholar 

  2. Aoyagi T, Suda H, Nagai M, Ogawa K, Suzuki J, Takeuchi T, Umezawa H (1976) Aminopeptidase activities on the surface of mammalian cells. Biochim Biophys Acta 452:131–143

    Article  PubMed  CAS  Google Scholar 

  3. Aoyagi T, Tobe H, Kojima F, Hamada M, Takeuchi T, Umezawa H (1978) Amastatin, an inhibitor of aminopeptidase A produced by actinomycetes. J Antibiot (Tokyo) 31:636–638

    Article  CAS  Google Scholar 

  4. Aoyagi T, Yamamoto T, Kojiri K, Kojima F, Hamada M, Takeuchi T, Umezawa H (1978) Forphenicine, an inhibitor of alkaline phosphatase produced by actinomycetes. J Antibiot (Tokyo) 31:244–246

    Article  CAS  Google Scholar 

  5. Blomgren H, Strender LE, Edsmyr F (1979) Studies on the immunostimulatory effect of bestatin in vitro and in vivo. Bestatin Conference, March 10, Tokyo

    Google Scholar 

  6. Ishizuka M, Aoyagi T, Takeuchi T, Umezawa H (1979) Further study of effect of bestatin on immune responses. Bestatin Conference, March 10, Tokyo

    Google Scholar 

  7. Ishizuka M, Iinuma H, Takeuchi T, Umezawa H (1972) Effect of diketocoriolin B on antibody-formation. J Antibiot (Tokyo) 25:320

    Article  CAS  Google Scholar 

  8. Kawamata J (1979) Effect of bestatin on cachexia caused by human uterus carcinoma inoculated to nude mice. Bestatin Conference, March 10, Tokyo

    Google Scholar 

  9. Kunimoto T, Umezawa H (1973) Kinetic studies on the inhibition of (Na+-K+)-ATPase by diketocoriolin B on antibody-formation. Biochim Biophys Acta 318:78–90

    Article  PubMed  CAS  Google Scholar 

  10. Suda H, Aoyagi T, Takeuchi T, Umezawa H (1976) Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomers. Arch Biochem Biophys 177:196–200

    Article  PubMed  CAS  Google Scholar 

  11. Tsuruo T, Kataoka T, Tsukagoshi S, Sakurai K (1979) Effect of bestatin on lymph-node metastasis of P388. Bestatin Conference, March 10, Tokyo

    Google Scholar 

  12. Umezawa H (1972) Enzyme inhibitors of microbial origin. University of Tokyo Press, Tokyo

    Google Scholar 

  13. Umezawa H (1976) Structures and activities of protease inhibitors of microbial origin. Methods Enzymol 45:678–695

    Article  PubMed  CAS  Google Scholar 

  14. Umezawa H (1977) Recent advances in bioactive microbial secondary metabolites. Jpn J Antibiot [Suppl] 30:138–163

    CAS  Google Scholar 

  15. Umezawa H, Aoyagi T, Hazato T, Uotani K, Kojima F, Hamada M, Takeuchi T (1978) Esterastin, an inhibitor of esterase, produced by actinomycetes. J Antibiot (Tokyo) 31:639–641

    Article  CAS  Google Scholar 

  16. Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T (1976) Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot (Tokyo) 29:97–99

    Article  CAS  Google Scholar 

  17. Umezawa H, Ishizuka M, Aoyagi T, Takeuchi T (1976) Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and leucine aminopeptidase. J Antibiot (Tokyo) 29:857–859

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Umezawa, H. (1981). Fundamental Studies on Bestatin: A Small Molecular Microbial Product Enhancing Immune Responses. In: Carter, S.K., Sakurai, Y., Umezawa, H. (eds) New Drugs in Cancer Chemotherapy. Recent Results in Cancer Research, vol 76. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81565-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81565-2_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81567-6

  • Online ISBN: 978-3-642-81565-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics